Search

Author/Creator Dull, Peter

1. 1084Persistence of Meningococcal Antibodies and Response to a Booster Dose after a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents. (December 2014)

Authors:
Saez-Llorens, Xavier; Vaca, Diana Catalina Aguilera; Abarca, Katia; Maho, Emmanuelle; Han, Linda; Smolenov, Igor; Dull, Peter
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S319
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine. Issue 3 (11th January 2017)

Authors:
Read, Robert C.; Dull, Peter; Bai, Xilian; Nolan, Kate; Findlow, Jamie; Bazaz, Rohit; Kleinschmidt, Annett; McCarthy, Maggie; Wang, Huajun; Toneatto, Daniela; Borrow, Ray
Journal:
Vaccine
Issue:
Volume 35:Issue 3(2017)
Page Start:
427
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women. Issue 15 (4th April 2016)

Authors:
Leroux-Roels, Geert; Maes, Cathy; Willekens, Julie; De Boever, Fien; de Rooij, Richard; Martell, Leah; Bedell, Lisa; Wittke, Frederick; Slobod, Karen; Dull, Peter
Journal:
Vaccine
Issue:
Volume 34:Issue 15(2016)
Page Start:
1786
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response. (February 2016)

Authors:
Berry, Scott M; Petzold, Elizabeth A; Dull, Peter; Thielman, Nathan M; Cunningham, Coleen K; Corey, G Ralph; McClain, Micah T; Hoover, David L; Russell, James; Griffiss, J McLeod; Woods, Christopher W
Journal:
Clinical trials
Issue:
Volume 13:Number 1(2016)
Page Start:
22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395–402]. Issue 24 (31st May 2017)

Authors:
Iro, Mildred A.; Snape, Matthew D.; Voysey, Merryn; Jawad, Sena; Finn, Adam; Heath, Paul T.; Bona, Gianni; Esposito, Susanna; Diez-Domingo, Javier; Prymula, Roman; Odueyungbo, Adefowope; Toneatto, Daniela; Dull, Peter; Pollard, Andrew J.
Journal:
Vaccine
Issue:
Volume 35:Issue 24(2017)
Page Start:
3279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗